Revel, of the Weizmann Institute of Science, who discovered Rebif, a treatment for multiple sclerosis, and a major competitor of Teva Pharmaceutical Industries Ltd.'s (NYSE: TEVA; TASE: TEVA) Copaxone. The company is engaged in the cutting edge of stem ...
See all stories on this topic »
↧
Alzheimer treatment co Neuronix files for TASE IPO Alerts - "Teva Pharmaceutical Industries Ltd."
↧
